Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vassiliki Tzanetakou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Dermatology|March 27, 2019
Childhood VitiligoElectra Nicolaidou, Styliani Mastraftsi, Vassiliki Tzanetakou, et al.
Expert Opinion on Drug Safety|February 27, 2020
Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativaVassiliki Tzanetakou, Dimitra Stergianou, Evangelos J Giamarellos-Bourboulis
Clinical, Cosmetic and Investigational Dermatology|May 17, 2017
Methotrexate: an effective monotherapy for refractory generalized morpheaEftychia Platsidaki, Vassiliki Tzanetakou, Anargyros Kouris, et al.
International Journal of Dermatology|April 1, 2018
A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativaClio Dessinioti, Vassiliki Tzanetakou, Chrisa Zisimou, et al.
Journal of Dermatological Science|April 27, 2017
A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativaClio Dessinioti, Chrisa Zisimou, Vassiliki Tzanetakou, et al.
International Journal of Dermatology|February 20, 2019
Imiquimod 3.75% for field-directed therapy of actinic keratosis: results of a prospective case-series study in GreeceAngeliki Befon, Vassiliki Tzanetakou, Antonios Panagiotopoulos, et al.
Dermatology (Basel, Switzerland)|January 5, 2021
Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to AdalimumabDimitra Stergianou, Vassiliki Tzanetakou, Maria Argyropoulou, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 16, 2021
Factors associated with increased suicidality risk following referral for isotretinoin commencementAndreas S Lappas, Lori Edwards Suarez, Vassiliki Tzanetakou, et al.
The Journal of Investigative Dermatology|May 21, 2023
Immune Classification of Hidradenitis Suppurativa: Modulation by SecukinumabDimitra Stergianou, Styliani Micha, Vassiliki Tzanetakou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 29, 2014
Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinomaAthina Chounta, Christofer Ellinas, Vassiliki Tzanetakou, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Dermatology|March 27, 2019
Childhood VitiligoElectra Nicolaidou, Styliani Mastraftsi, Vassiliki Tzanetakou, et al.
Expert Opinion on Drug Safety|February 27, 2020
Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativaVassiliki Tzanetakou, Dimitra Stergianou, Evangelos J Giamarellos-Bourboulis
Clinical, Cosmetic and Investigational Dermatology|May 17, 2017
Methotrexate: an effective monotherapy for refractory generalized morpheaEftychia Platsidaki, Vassiliki Tzanetakou, Anargyros Kouris, et al.
International Journal of Dermatology|April 1, 2018
A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativaClio Dessinioti, Vassiliki Tzanetakou, Chrisa Zisimou, et al.
Journal of Dermatological Science|April 27, 2017
A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativaClio Dessinioti, Chrisa Zisimou, Vassiliki Tzanetakou, et al.
International Journal of Dermatology|February 20, 2019
Imiquimod 3.75% for field-directed therapy of actinic keratosis: results of a prospective case-series study in GreeceAngeliki Befon, Vassiliki Tzanetakou, Antonios Panagiotopoulos, et al.
Dermatology (Basel, Switzerland)|January 5, 2021
Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to AdalimumabDimitra Stergianou, Vassiliki Tzanetakou, Maria Argyropoulou, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|July 16, 2021
Factors associated with increased suicidality risk following referral for isotretinoin commencementAndreas S Lappas, Lori Edwards Suarez, Vassiliki Tzanetakou, et al.
The Journal of Investigative Dermatology|May 21, 2023
Immune Classification of Hidradenitis Suppurativa: Modulation by SecukinumabDimitra Stergianou, Styliani Micha, Vassiliki Tzanetakou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 29, 2014
Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinomaAthina Chounta, Christofer Ellinas, Vassiliki Tzanetakou, et al.
Pageof 2